
ResMed Inc.
RMDNYSEHealthcareMedical - Instruments & Supplies
Previous close
$231.52
+$3.08 · +1.35%
RMD company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
99
Deep Value
Momentum
40
Weakening
Sentiment
72
Bullish
Risk resilience
57
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Michael J. Farrell
- Listed since
- Jun 2, 1995
- Employees
- 11,370
Market position
Day range
Current $231.52
52-week range
Current $231.52
- Open
- $229.44
- Previous close
- $228.44
- Volume
- 925.81K
- 0.62× average
- Average volume
- 1.5M
- Average daily volume
- Market cap
- 33.58B USD
- Beta
- 0.75
- Market reference 1
- 50-day average
- $206.94
- +11.88% above average
- 200-day average
- $229.13
- +1.04% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 27.56B USD
- P/E (TTM)
- 22.18×
- P/B (TTM)
- 5.09×
- P/S (TTM)
- 5.94×
- EV / EBITDA
- 12.84×
- Earnings yield
- 5.40%
- Free cash flow yield
- 5.85%
- Dividend yield
- 1.06%
Profitability & efficiency
- Gross margin
- 61.16%
- Operating margin
- 33.48%
- Net margin
- 26.94%
- Return on equity
- 23.13%
- Return on assets
- 16.99%
- Return on invested capital
- 19.11%
Financial health
- Debt / equity
- 0.13×
- Current ratio
- 3.1×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 5.65B USD | 5.15B USD | 4.69B USD | 4.22B USD | 3.58B USD |
| Cost of goods sold | 2.2B USD | 2.09B USD | 2.03B USD | 1.87B USD | 1.55B USD |
| Gross profit | 3.46B USD | 3.05B USD | 2.66B USD | 2.36B USD | 2.02B USD |
| Research and development | 378.29M USD | 331.28M USD | 307.53M USD | 287.64M USD | 253.58M USD |
| Selling, general, and administrative | 817.39M USD | 991.02M USD | 917.14M USD | 874M USD | 739.37M USD |
| Operating expenses | 1.57B USD | 1.37B USD | 1.34B USD | 1.22B USD | 1.02B USD |
| Interest expense | 29.03M USD | 12.61M USD | 45.71M USD | 47.38M USD | 22.31M USD |
| Depreciation and amortization | 197.86M USD | 235.81M USD | 216.21M USD | 196.52M USD | 193.84M USD |
| Operating income | 1.89B USD | 1.69B USD | 1.32B USD | 1.13B USD | 1B USD |
| Net income | 1.52B USD | 1.4B USD | 1.02B USD | 897.56M USD | 779.44M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 82%
- 9 beats, 1 miss, 1 met estimate
- Average EPS surprise
- +3.31%
- 11 comparable reports
- Latest EPS result
- 2.95
- Estimate 2.89 · Beat by 2.08%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$238.7
3.10% upsidePrice history unavailable
High $300Average $238.7Low $213Rating distribution
35 ratingsRecent analyst actions
RMD news
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Aug 31, 2010 | 2:1 | — | — |
Stock split | Oct 3, 2005 | 2:1 | — | — |
Stock split | Apr 3, 2000 | 2:1 | — | — |
Stock split | Nov 17, 1998 | 2:1 | — | — |
Effective Aug 31, 2010
2:1
Effective Oct 3, 2005
2:1
Effective Apr 3, 2000
2:1
Effective Nov 17, 1998
2:1
RMD peers
ETFs holding RMD
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI974.64M0.04%2.3T USD0.03%$378.24+0.44%
Vanguard S&P 500 ETFVOO803.32M0.05%1.7T USD0.03%$703.71+0.39%
Vanguard Morningstar Mid-Cap ETFVO662.34M0.29%224.7B USD0.03%$82.97+0.53%
iShares Core S&P 500 ETFIVV446.57M0.05%891.84B USD0.03%$769.31+0.39%
State Street SPDR S&P 500 ETFSPY412.1M0.05%817.87B USD0.09%$765.72+0.41%
Vanguard Morningstar Growth ETFVUG391.04M0.10%372B USD0.03%$87.50+0.38%
First Trust Rising Dividend Achievers ETFRDVY327.93M1.30%25.43B USD0.47%$81.95+0.55%
State Street Health Care Select Sector SPDR ETFXLV238.37M0.53%44.76B USD0.08%$174.62+1.29%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 974.64M
- Weight
- 0.04%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard S&P 500 ETFVOO- Market value
- 803.32M
- Weight
- 0.05%
- AUM
- 1.7T USD
- Expense ratio
- 0.03%
- Price / 1D
- $703.71+0.39%
Vanguard Morningstar Mid-Cap ETFVO- Market value
- 662.34M
- Weight
- 0.29%
- AUM
- 224.7B USD
- Expense ratio
- 0.03%
- Price / 1D
- $82.97+0.53%
iShares Core S&P 500 ETFIVV- Market value
- 446.57M
- Weight
- 0.05%
- AUM
- 891.84B USD
- Expense ratio
- 0.03%
- Price / 1D
- $769.31+0.39%
State Street SPDR S&P 500 ETFSPY- Market value
- 412.1M
- Weight
- 0.05%
- AUM
- 817.87B USD
- Expense ratio
- 0.09%
- Price / 1D
- $765.72+0.41%
Vanguard Morningstar Growth ETFVUG- Market value
- 391.04M
- Weight
- 0.10%
- AUM
- 372B USD
- Expense ratio
- 0.03%
- Price / 1D
- $87.50+0.38%
First Trust Rising Dividend Achievers ETFRDVY- Market value
- 327.93M
- Weight
- 1.30%
- AUM
- 25.43B USD
- Expense ratio
- 0.47%
- Price / 1D
- $81.95+0.55%
State Street Health Care Select Sector SPDR ETFXLV- Market value
- 238.37M
- Weight
- 0.53%
- AUM
- 44.76B USD
- Expense ratio
- 0.08%
- Price / 1D
- $174.62+1.29%
Continue in GoAI
Research RMDresearch.disclaimer











